Cramer’s lightning round: Editas Medicine is not a buy

Cramer’s lightning round: Editas Medicine is not a buy


DraftKings Inc: “They are in a battle, a pure battle to try to get market share and right now, there is no sign that the battle is over. … I do think they’ll win.”

SoFi Technologies Inc: “I can’t tell you to sell it. But I can also tell you, maybe I’m not the answer on this stock because holy cow, it hasn’t stopped [going down in price] and I thought it would have.”

Editas Medicine Inc: “You can not buy growth stocks that have no hope of making money. Not in this environment.”

Altria Group Inc: “It is tobacco, and that’s not what I’m fond of. … If you don’t care, then it’s fine.”



Source

Nearly one-third of major U.S. housing markets now see falling home prices
Business

Nearly one-third of major U.S. housing markets now see falling home prices

A sign is posted in front of a home for sale in San Rafael, California, on Aug. 7, 2024. Justin Sullivan | Getty Images Overinflated home prices, high mortgage rates, rising supply and falling demand are all joining forces to cool the nation’s housing market. Annual home price growth in June was just 1.3%, down […]

Read More
Starbucks employees to return to the office four days a week — or take a payout
Business

Starbucks employees to return to the office four days a week — or take a payout

The Starbucks headquarters is seen at Starbucks Center on July 3, 2024 in Seattle, Washington. David Ryder | Getty Images Starbucks corporate employees will have to return to the office four days a week starting in October, the company announced on Monday. For workers who would prefer to leave the company instead of heading back […]

Read More
Tax cuts for private jet buyers expected to lead to surge in sales
Business

Tax cuts for private jet buyers expected to lead to surge in sales

Private jets parked at the Friedman Memorial Airport during the Allen & Company Sun Valley Conference on July 10, 2025 in Sun Valley, Idaho. Kevin Dietsch | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive […]

Read More